- $288.68bn
- $313.21bn
- $54.07bn
REG - AstraZeneca PLC - Result of AGM
AnnouncementREG - AstraZeneca PLC - Imfinzi+Imjudo improves PFS in early liver cancer
AnnouncementREG - AstraZeneca PLC - Total Voting Rights and Admission of Shares
AnnouncementRCS - Brit Utd ProvAscBUPA - Bupa Announces Non-Executive Director Appointments
AnnouncementREG - AstraZeneca PLC - Efzimfotase alfa Ph3 program show positive results
AnnouncementREG - ConnectingExcellence - Appointment of Chief Performance & Growth Officer
AnnouncementREG - AstraZeneca PLC - Tozorakimab met OBERON/TITANIA primary endpoints
AnnouncementREG - AstraZeneca PLC - Notification of Admission of Shares
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in EU for early gastric cancer
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementRCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca prices a $2bn bond offering
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - Directorate change
Announcement